CD82 and ovarian cancer: The data of the present study together with those of our previous investigations in human ovarian cancer cells, strongly support the notion that KAI1-SP does not only counteract the tumor suppressive function of KAI1-WT, but - beyond this - drastically promotes tumor cell biological activities in favor of tumor progression.